News ArticleMahindra & Mahindra Financial Services Announces Registrar KFin Technologies Corporate Office Shift Effective December 1, 2026
RTA's new premises located at Rajapushpa West Avenue, Telangana; existing Registered Office in Mumbai remains unchanged
Mahindra & Mahindra Financial Services Limited has announced that its Registrar and Share Transfer Agent, KFin Technologies Limited, will relocate its Corporate Office to a new address in Telangana effective from December 1, 2026. The company's investors and stakeholders are advised to update their records accordingly.
Mahindra & Mahindra Financial Services Limited
General / Other
Mahindra & Mahindra Financial Services Ltd has informed investors that its Registrar and Share Transfer Agent, KFin Technologies Limited, will move its Corporate Office to a new location in Telangana starting December 1, 2026.
The current Corporate Office of KFin Technologies Limited is situated at Selenium Tower B, Gachibowli, Financial District, Hyderabad, Telangana.
The new Corporate Office will be at 6th, 23rd, 24th, 25th Floor, South Tower, Rajapushpa West Avenue, Survey No. 115, Kokapet, Serilingampally Mandal, Ranga Reddy District, Telangana – 500075.
All correspondence and documents for the RTA's Corporate Office should be directed to the new address from December 1, 2026 onwards.
The Registered Office of KFin Technologies Limited remains unchanged at 301, The Centrium, 3rd Floor, 57, Lal Bahadur Shastri Road, Nav Pada, Kurla (West), Mumbai – 400070, Maharashtra.
Highlights
- Corporate Office of KFin Technologies Limited relocates effective 1st December 2026.
- New address in Ranga Reddy District, Telangana, replacing previous Hyderabad location.
- Existing Registered Office in Mumbai remains unchanged.
- Investors advised to update records and send future correspondence to the new Corporate Office address.
- Contact phone number and email for KFin Technologies provided for investor communication.
Key Data Snapshot
What happened
- Mahindra & Mahindra Financial Services Limited has received notification from KFin Technologies Limited about shifting its Corporate Office.
- The move will be effective from 1st December 2026.
- Investors and stakeholders are requested to send all future correspondence to the new Corporate Office address post-relocation.
Key details
- New RTA Corporate Office is located at Rajapushpa West Avenue, Kokapet, Serilingampally Mandal, Telangana.
- Existing Corporate Office was at Gachibowli, Hyderabad, Telangana.
- Registered Office of the RTA remains in Mumbai with no change in address.
- Contact details including telephone number and emails provided for communication.
Regulatory and governance context
- Notification filed with BSE Limited (Scrip Code: 532720) and National Stock Exchange of India Ltd (Symbol: M&MFIN).
- The announcement is also uploaded on Mahindra & Mahindra Financial Services' website under investor relations and regulatory filings.
Highlights
- Corporate Office of KFin Technologies Limited relocates effective 1st December 2026.
- New address in Ranga Reddy District, Telangana, replacing previous Hyderabad location.
- Existing Registered Office in Mumbai remains unchanged.
- Investors advised to update records and send future correspondence to the new Corporate Office address.
- Contact phone number and email for KFin Technologies provided for investor communication.
Disclosures
- Disclosure under Regulation of stock exchanges
Source Information
More News on General / Other
View allLatest corporate announcements and market updates in General / Other.
Biocon Limited Reports Q2 FY2027 Profit of Rs. 917 Million and Announces New CTO Appointment
Biocon Limited disclosed its unaudited standalone financial results for the quarter and half year ending September 30, 2026, with a quarterly profit of Rs. 917 million. The board also approved the resignation of CTO Dr. Mandar Shrikant Ghatnekar effective December 31, 2026, and the appointment of Mr. Mukesh Rathi as CTO starting January 1, 2027.
Read Full Story
Biocon Reports Q2 FY27 Total Income of Rs 4,423 Crore With Biopharma Revenue Up 5% and $400 Million Pertuzumab Deal
Biocon Limited announced consolidated total income of Rs 4,423 crore for the second quarter of fiscal year 2027, with biopharma revenues increasing by 5% year-on-year to Rs 3,583 crore. The company's EBITDA was reported at Rs 865 crore and net profit at Rs 41 crore. A significant highlight includes securing a 10-year biosimilar Pertuzumab PDP partnership in Brazil valued at about USD 400 million.
Read Full Story
Zydus Lifesciences Posts Rs. 79,096 Million Revenue in Q2 FY27 with Net Profit at Rs. 9,255 Million
Zydus Lifesciences Limited reported strong revenue growth of 29% year-on-year in Q2 FY27 at Rs. 79,096 million, driven by its branded pharma businesses in India, North America, and international markets. However, net profit declined 27% to Rs. 9,255 million, and EBITDA dropped 6% to Rs. 18,945 million, reflecting cost and margin pressures.
Read Full Story
